References
- Gemzell-Danielsson K, Lalitkumar S. Second trimester medical abortion with mifepristone–misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters. 2008;16(31 Suppl):162–172.
- Schreiber CA, Creinin MD, Atrio J, et al. Mifepristone pretreatment for the medical management of early pregnancy loss. N Engl J Med. 2018;378(23):2161–2170.
- Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). 2021. Technical data sheet Mifegyne 200 mg tablets [in Spanish]; [cited 2021 July 15]. Available from: https://cima.aemps.es/cima/dochtml/ft/62728/FT_62728.html#5-propiedades-farmacol-gicas.
- Henkel A, Shaw KA. Advances in the management of early pregnancy loss. Curr Opin Obstet Gynecol. 2018;30(6):419–424.
- Chaudhuri P, Datta S. Mifepristone and misoprostol compared with misoprostol alone for induction of labor in intrauterine fetal death: a randomized trial. J Obstet Gynaecol Res. 2015;41(12):1884–1890.
- Kapp N, Borgatta L, Stubblefield P, et al. Mifepristone in second-trimester medical abortion: a randomized controlled trial. Obstet Gynecol. 2007;110(6):1304–1310.
- Kaushal A, Kaur K, Kaur P, et al. Mifepristone plus misoprostol versus misoprostol for second trimester termination of pregnancy. Int J Curr Adv Res. 2017;6:4472–4475.
- Kulkarni KK. Pre-induction with mifepristone for second trimester termination of pregnancy. J Obstet Gynaecol India. 2014;64(2):102–104.
- Bedi PK, Saini A. Randomized control trial to compare the effectiveness of mifepristone followed by misoprostol at 12 hours interval versus misoprostol alone in second trimester medical termination of pregnancy. Int J Reprod Contracept Obstet Gynecol. 2018;7(8):3299–3304.